Nanocharacterization

Nanocharacterization is providing a comprehensive understanding of materials at the nanoscale. In this context, it involves the analysis and evaluation of pharmaceutical formulations, drug delivery systems, and biomaterials at dimensions ranging from 1 to 100 nanometers. The ability to scrutinize materials at such a minuscule scale allows for a deeper insight into their physicochemical properties, structural features, and interactions, which are critical for optimizing drug performance and ensuring therapeutic efficacy.

Techniques such as atomic force microscopy, transmission electron microscopy, and dynamic light scattering are employed for nanocharacterization, enabling researchers to explore parameters like particle size, shape, surface charge, and drug release kinetics. This meticulous analysis aids in the design and development of nanoscale drug delivery systems, facilitating targeted and controlled release of pharmaceutical agents. Moreover, nanocharacterization contributes to the assessment of biocompatibility, stability, and safety of nanopharmaceuticals, fostering advancements in precision medicine and personalized healthcare. As the pharmaceutical industry continues to harness the potential of nanotechnology, nanocharacterization emerges as an indispensable tool for ensuring the quality, safety, and efficacy of nanomedicines.

Committee Members
Speaker at Drug Delivery Events - Vladlen Slepak

Vladlen Slepak

University of Miami Miller School of Medicine, United States
Speaker at Drug Delivery Events - Yong Xiao Wang

Yong Xiao Wang

Albany Medical College, United States
Speaker at Pharmaceutical Conference - Consolato M Sergi

Consolato M Sergi

Universities of Alberta and Ottawa, Canada
Speaker at Drug Delivery Events - Huiqin Yang

Huiqin Yang

ICON Clinical Research Ltd, United Kingdom

Submit your abstract Today

Youtube
Watsapp